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The aim of this study was to evaluate the in vivo antinociceptive and antipyretic activities of Marrubium deserti  
De Noé infusion extract. Antinociceptive effect was evaluated by acetic acid induced writhing response, formalin-induced 
paw licking and the hot plat method in mice, while antipyretic activity was tested by brewer’s yeast induced pyrexia in rats. 
In each test, we examined the doses of 250, 500 and 1000 mg/kg body weight (bw) of the extract. The infusion extract 
produced dose-dependent antinociceptive effect against chemically and thermally induced nociceptive pain stimuli in mice. 
In acetic acid induced writhing test, the inhibition percentage of writhing response was 49.12% at 1000 mg/kg bw 
(p<0.001). This extract also significantly (p<0.001) inhibited the licking response of the formalin test at 1000 mg/kg bw in 
both the early phase (64.39%) and the late phase (70.75%). In the hot plate method, the infusion extract significantly 
(p<0.001) increased the reaction time to heat sensation to 58.21% at 1000 mg/kg bw Moreover, the extract possessed an 
excellent (p<0.001) antipyretic effect and even better than the reference drug. These findings indicate that M. deserti  
De Noé infusion extract possesses antinociceptive and antipyretic activities which could be due to the presence of bioactive 
compounds in this plant. 
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Pain is defined as an unpleasant sensory and 
emotional experience associated with tissue damage1-
2. Analgesics are the substances which decrease pain 
sensation by increasing pain threshold to external 
stimuli3. The Non Steroidal Anti-Inflammatory Drugs 
(NSAIDs) are among the most widely used of all 
therapeutic agents. They are useful in the treatment of 
pain and some inflammatory diseases. However, long-
term use of the NSAIDs has been associated  
with gastrointestinal ulceration, bleeding and 
nephrotoxicity4-5. Therefore, the investigation of new 
analgesics agents are still a challenge for medical 
community. As a result more people are turning to 
herbal medicines for alternative treatment of pain. 
Herbal drugs have fewer side effects and are largely 
required as substitute therapeutics6. 
Traditional medicine is a combination of 
knowledge and practice, used in diagnosing, 
preventing and eliminating several diseases. It may 
rely on past experience and observation handed down 
from generation to generation verbally or in writing. 
Preservation of this information can be a valuable 
policy for good usage of natural sources. Lamiaceae 
family has been holding a place of value for hundreds 
of years due to the numerous aromatic species which 
used as components of various herbal treatments7. The 
genus Marrubium is represented by 97 species which 
are widely spread over the temperate and warm 
regions. Marrubium species are indigenous in Europe, 
the Mediterranean area and in Asia8-10. Among them, 
Marrubium deserti De Noé known as Merriouet 
saharaui or Djaîdis an endemic herb of central and 
north Algerian Sahara growing in dry pastures. This 
plant is a shrub with blancher’s leaves and stems. The 
leaves are velvety and opposite, and are generally 
terminated by three large teeth of variable forms. The 
flowers are pale pink11. In Algerian traditional 
medicine, the leaves and the young buds of M. deserti 
are used in the form of a decoction as a remedy for 
respiratory diseases like fever, diabetes and as 
diuretic12. Furthermore, it is frequently used in 
traditional medicinal for treating digestive disorders 
as antispasmodic and as local treatment against 
scorpion stings and in case of allergy10,13. ————— *Corresponding author 
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The biological activities of many Marrubium  
species and their components are reported and it has 
been showed to possess antinociceptive14-15, 
antioxidant16-19, antimicrobial20, antifungal, cytotoxic21, 
antioedematogenic22, hypolipidemic, hypoglycemic23, 
hepatoprotective24, antiproliferative25, vasorelaxant26 
and anti-inflammatory effects27.  
The essential oil from aerial parts of M. deserti De 
Noé, obtained by hydro-distillation, was analyzed by 
Gaz Chromatography (GC) and Gaz Chromatography - 
Mass Spectrometry (GC-MS). Thirty-seven 
compounds were identified in the oil, with germacrene-
D, as the major component (45.7%). This oil was 
characterized by significant hydrocarbon fraction 
(78.1%) and the predominance of sesquiterpenes 
(67.4%)28. 
The best known and first isolated diterpenoid was 
obtained from M. vulgare in 1842. It was characterized 
as marrubiine. This furanie labdane diterpene is, in 
part, responsible for therapeutic properties of 
Marrubium sp. The genus Marrubium is a rich source 
of diterpenoids, flavonoids and phenylethanoid 
glycosides29. 
The purpose of the present study was to evaluate 
the antinociceptive and antipyretic activities of the 
infusion extract from M. deserti’s aerial parts in 
animal models in order to establish a probable 
mechanism of action and to justify the traditional uses 
of this plant. The acute toxicity study of the plant was 
also carried out. 
 
Materials and Methods 
 Plant Material 
Aerial parts of M. deserti De Noé were collected 
from Ain Zaatout town (Biskra, northeast of Algeria) 
in 2012. The plant species has been identified based 
on the flora of Quezel and Santa11 and according to 
the validation of the national institute of the forestry 
research (INRF), Tamanr asset, Algeria. A voucher 
specimen of M. deserti De Noé (N° 5821-
PAM/LRZA/USTHB) has been deposited at the 
Laboratory of Research on Arid Zones (LRZA), 
Algiers, Algeria. 
The aerial parts were dried and pulverized to 
powder and preserved for further studies. The 
infusion extract was prepared according to the 
traditional method; the fine powder was dissolved in 
boiling normal saline water (0.9% NaCl). The filtrate 
was used for biological tests on animals at different 
doses. 
Animals 
Wistar rats (Rattus norvegicus) (160-200 g) and 
Albino mice (Mus musculus) (25±5 g) of both sexes 
were procured from Pasteur institute, Algiers, Algeria. 
Animals were housed in plastic cages at the 
temperature of 24±2°C and 50±5% relative humidity, 
with a 12 light/dark cycle respectively. The access to 
standard pellet diet purchased from the national office 
of animal feed, Bejaia (ONAB) and water ad libitum 
were allowed for animals. The experiments were 
carried out in accordance with the current guidelines 
for the care of laboratory animals, and the ethical 
guidelines for investigations of experimental pain in 
conscious animals, as specified by the National 
Research Council Academies30. The number of 
animals was the minimum necessary to demonstrate 
the consistent effects of the drug treatments. 
 
Drugs and Reagents 
The chemicals (acetic acid and formalin) used were 
purchased from Sigma Aldrich Gmbh (Steinheim, 
Germany). Paracetamol and normal saline water 
(0.9% NaCl) were used as the standard drugs and the 
control in all studies. 
 
Phytochemical Screening 
The phytochemical screening of the infusion 
extract of M. deserti De Noé was performed following 
the method of Harborne31 and Siddiqui et al.32. 
Phytochemical constituents such as flavonoids, 
terpenoids, saponins, alkaloids, tannins, carotenoids, 
quinines, lipoid and steroids were qualitatively 
analyzed.  
 
Acute Toxicity of M. deserti De Noé in Mice 
The acute toxicity study of M. deserti De Noé 
infusion extract was assessed in mice of both sexes, as 
per OECD-423 guidelines (organization for economic 
co-operation and development)33, with slight 
modifications. Mice were separated into six groups, 
each consisting of five males and five females mice 
(n=10). The infusion extract was administered with 
the doses of 5 g/kg, 7 g/kg, 9 g/kg, 11 g/kg and 13 
g/kg bw The control group received normal saline 
water at a dose of 20 mL/kg bw Food and water were 
withheld 4 h after the drugs administration and the 
mice were closely observed for the 4 h and then once 
a day up to 14 days. 
 
Antinociceptive Studies 
 
Acetic Acid Induced Writhing Response in Mice 
The analgesic activity was evaluated using acetic 
acid induced writhing method in mice following the 
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method of Sawadogo et al.34 with slight modification35-
36. The acetic acid was administered intraperitoneally to 
animals to create pain sensation. The animals were 
divided into five groups with six males in each (n=6), 
they were fasted for 19 h prior to experiments. The 
groups 1, 2 and 3 were treated with 250, 500 and 1000 
mg/kg bw of the infusion extract; while the groups 4 
and 5 received normal saline (control) and paracetamol 
(100 mg/kg bw) as a drug reference respectively. The 
extract and vehicle were administered orally 30 min 
before the intraperitoneal injection of the acetic acid 
(0.6%, v/v in normal saline, 10 mL/kg bw), and the 
animals were placed individually in transparent plastic 
cages for counting the number of writhing they made in 
10 min beginning just 5 min after their administration. 
Contraction of the abdominal muscles accompanied by 
stretching the hind limbs was accepted as writhing 
movements37. A significant reduction in the number of 
writhing compared to the control animals was 
considered as an antinociceptic response38. The 
analgesic effect was calculated as the inhibition 
percentage of writhing. 
 
% inhibition = (1 – Wt/Wc)  100 
 
Where Wc is the average writhing response of the 
control group and Wt is the average writhing response 
of the treated group. 
 
Formalin Induced Paw Licking in Mice 
In this experiment, we used the method of Ullah et al.38 
with slight modifications39, where pain was induced by 
formalin. The five groups of mice (n=6); vehicle control 
(normal saline water, 0.5 mL), paracetamol (100 mg/kg 
bw) and the infusion extracts of the plant (250, 500 and 
1000 mg/kg bw), were administered orally thirty minutes 
after the subcutaneously injection of 50 µL of a freshly 
prepared 0.6% formalin solution that was injected under 
the plantar surface of the right hind paw of each mouse. 
The time in second spent in licking and biting responses 
of the injected paw was taken as an indicator of pain 
response. Antinociceptive effect was determined in two 
phases. The early phase was recorded during the first 5 
min, while the late phase was recorded during the last 15 
to 30 min. The inhibition percentage of the paw licks for 
both phases calculated by following formula:  
 
Do-Dt% inhibition = 100Do   
Where Do is the average number of paw licks of the 
control group and Dt is the number of paw licks of the 
treated group. 
Hot Plate Test in Mice 
The ‘hot-plate’ test (thermal test) used in this study 
was described by Lanhers et al.40 and Ojewole41 to 
evaluate the analgesic activity. The temperature of the 
hot plate was regulated at 55°±0.5°C. The five groups 
of 6 mice each were fasted for 18 h and water was 
provided ad libitum. The mice of each group were 
placed on the hot plate in order to obtain its response 
to electrical heat induced pain stimulus. Licking of the 
paws or jumping out of the hot plate was taken as an 
indicator of pain response. Reaction time in seconds 
was taken as the interval between the instant that the 
animal reaches the hot plate till the moment that the 
animal licks its paws or jumps out. Each mouse was 
treated orally with control (normal saline water, 0.5 
mL), paracetamol (100 mg/kg bw) or with the 
infusion extract at doses of 250, 500, 1000 mg/kg bw 
Thirty minutes after treatment, the reaction times of 
each group were evaluated five times individually 
each hour. The percentage thermal pain stimulus 
protection was calculated as the formula: 
 
Ta - Tb% protection = 100Ta   
 
Where Ta is the reaction time (s) after drug 
administration; Tb is the reaction time (s) before drug 
administration. 
 
Antipyretic Activity in Rats 
Antipyretic activity of M. deserti De Noé infusion 
extract was measured following the method described 
by Fadeyi et al.42. Pyrexia was induced in rats by 
subcutaneously injecting brewer's yeast suspension 
(20% w/v in normal saline, 10 mL/kg bw) into the 
rat's dorsum region. The initial rectal temperature of 
each rat was recorded 19 h before the yeast injection 
using a thermometer (Hartmann, Germany). The 
animals were then fasted for all the duration of the 
experiment, water was available ad libitum. Nineteen 
hours after the injection, the rectal temperature of 
each rat was recorded again to determine the pyretic 
response to yeast. Only rats that showed an increase 
in temperature of at least 0.5°C were selected and 
then rats were divided into five groups with six each 
(n=6). The infusion extract at doses of 250, 500 and 
1000 mg/kg bw of M. deserti De Noé were 
administered orally, while the control group was 
given normal saline water and the fifth group was 
treated with paracetamol (100 mg/kg bw). The 
temperature was measured at 1, 2, 3 and 4 h after drug 
and vehicle administrations.  
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Statistical Analysis 
Results are expressed as mean ± standard deviation 
(S.D.). Statistical significance was determined using 
one way ANOVA followed by Tukey's test for 
multiple comparisons. p-values<0.05 were considered 
as significant. 
 
Results 
 
Phytochemical Screening 
Phytochemical screening of the infusion extract of 
M. deserti De Noé revealed the presence of various 
bioactive components of which condensed tannins, 
catechic tannins, alkaloid, steroids, saponins and 
terpenoid (Table 1). In addition, we demonstrated the 
presence of high content of total phenolic compounds 
such as flavonoid, coumarine and glucosides. 
 
Acute Toxicity 
Oral administration of M. deserti’s infusion extract 
(up to 13 g/kg bw) did not show any signs of toxicity 
or behavioral changes in mice during the initial 4 
hours after M. deserti De Noé infusion extracts 
administration. During the 14 days of experiment, no 
deaths were observed in any of groups. 
 
Acetic Acid Induced Writhing Response in Mice 
The results of the analgesic effects of M. deserti De 
Noé infusion extracts on acetic acid induced writhing 
test in mice are presented in Table 2. The oral 
administration of the infusion extract significantly 
(p<0.001) decreased in a dose-dependent manner the 
number of writhing induced by acetic acid. The infusion 
extract at doses of 250 and 500 mg/kg b.w. showed 
28.07% and 42.10% inhibition of writhing respectively 
compared to the control group, whereas at higher dose 
(1000 mg/kg b.w.) significantly (p<0.001) was found to 
be the same as the standard drug (Paracetamol, 100 
mg/kg bw) with 49.12% inhibition. 
 
Formalin Induced Paw Licking 
The effect of M. deserti’s infusion extract on 
formalin induced paw licking in mice is shown in  
Fig. 1 and Fig. 2. There was a dose-dependent 
Table 1 — Phytochemical Analysis of the Infusion Extract of  
M. deserti De Noé Aerial Parts 
Extract Phytochemical 
constituents 
Results 
M. deserti’s infusion extract 
Flavonoids + + 
Lipoids - 
Condensed tannins + + + 
 
Catechic tannins + + 
Alkaloids + + + 
Steroids + 
Saponins + + + 
Quinines - 
 Terpenoids + 
 Coumarine + + + Glucosides + + + 
Symbols 
‘+++’ indicates presence in high concentration; 
‘++’ indicates presence in moderate concentration; 
‘+’ indicates presence in low concentration and 
‘-‘indicates absence of phytochemicals. 
 
Table 2 — Effect of the Infusion Extract of M. deserti De Noé on 
Acetic Acid-induced Writhing in Mice 
Groups Dose Number of writhing % Inhibition 
Control  57±1.7 - 
Paracetamol 100 mg/kg 29±1.4*** 49.12 
Infusion extract of 
M. deserti De Noé 
250 mg/kg 41±2.2***£ 28.07 
500 mg/kg 33±2.09***£ 42.10 
1000 mg/kg 29±1.7***£ 49.12 
Data represent mean±SD, (n=6). (-): no activity, ***p<0.001
significant from the control, £p<0.05 significant from the reference
drug (Paracetamol) (one way ANOVA followed by Tukey's test). 
  
Fig. 1 — Analgesic activity of the infusion extract of M. deserti De 
Noé aerial parts using formalin induced paw licking test on the early
phase Data represent mean±SD, (n=6), **p<0.01 significant 
compared to control, £p<0.05 significant compared to reference (one
way ANOVA followed by Tukey's test) 
 
  
Fig. 2 — Analgesic activity of the infusion extract of M. deserti
aerial parts using formalin induced paw licking method on late
phase Data represent mean±SD, (n=6), **p<0.01 significant 
compared to control, £p<0.05 significant compared to reference
(one way ANOVA followed by Tukey's test) 
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inhibitionof both phases in the extract tested of the 
formalin test. The infusion extract at the doses of 
500 and 1000 mg/kg bw significantly (p<0.001) 
inhibited the liking response in both the early phase 
(46.91%, and 64.39% respectively), and the late 
phase (57.69% and 70.75% respectively) of the 
formalin test, while at the dose of 250 mg/kg bw, the 
infusion extract exerted its action only on the early 
phase (44.75%) compared with the late phase 
(17.98%). The standard drug paracetamol (100 
mg/kg bw) showed a significant (p<0.001) inhibition 
in both phases, with 59.15% inhibition in the early 
phase and 76.09% inhibition in late phase.  
 
Hot Plate Test 
The results of the effect of M. deserti De Noé 
infusion extract on hot plate induced pain in mice are 
presented in Table 3 and Fig. 3. The infusion extract 
produced a dose-related significant (p<0.01) 
analgesic effect that continued for 4 h (58.21%) at the 
dose of 1000 mg/kg b.w. and until 3 h (37.57%) at the 
dose of 500 mg/kg bw, but at the low dose of 250 
mg/kg bw this extract presented a short analgesic 
activity (41.94%) against thermal pain stimulus that 
continued only 30 min after the administration. The 
paracetamol at the dose of 100 mg/kg bw increased 
the reaction time of heat sensation in mice with 
61.63% protection in the 3rd hour which was 
significantly greater (p<0.01) than that seen with the 
control group. 
Antipyretic Activity in Rats 
The effect of M. deserti De Noé infusion extracts 
on yeast induced pyrexia is shown in Table 4. 
Subcutaneous injection of yeast suspension clearly 
increased rectal temperature of rats 19 h after yeast 
injection. The oral administration of the infusion 
extract of M. deserti De Noé at the dose of 250 mg/kg 
and 500 mg/kg bw after 3 h of treatment caused a 
significant (p<0.01) decrease in temperature 
compared to control group. In contrast, the higher 
Table 3 — Analgesic Activity of the Infusion Extract of M. deserti De Noé Using the Hot Plate Method 
Groups Dose Reaction time at different time intervals (in s) 
0 h 30 min 1h 2 h 3 h 4 h 
Control  9.263±1.03 7.555±0.5 4.856±0.8 5.431±1.03 3.533±0.5 3.933±0.5 
Paracetamol 100 mg/kg 7.843±0.9* 16.028±1.7** 17.635±1.2** 20.445±1.3* 19.958±0.7** 20.063±0.6** 
Infusion  
extract of M. 
deserti De Noé 
250 mg/kg 8.425±0.3* 14.513±0.7** 11.44±1.2**£ 10.616±1.1**£ 9.12±0.8**£ 8.706±0.6**£ 
500 mg/kg 9.168±0.9* 14.601±1.04** 12.62±0.8**£ 14.686±0.8**£ 13.16±0.7**£ 10.293±0.3**£ 
1000 mg/kg 7.965±1.2* 9.355±0.7**£ 18.216±0.6** 16.853±0.5**£ 19.063±1.6** 18.261±1.07** 
Values represent mean±SD, (n=6), *p<0.05**p<0.01 significant compared to control, £p<0.05 significant compared to paracetamol (one
way ANOVA followed by Tukey's test). 
  
Fig. 3 — Protection percentage against thermal pain stimulus of
M. deserti De Noé infusion extract at different time intervals on
hot plate test £p<0.05 significant compared to paracetamol (one
way ANOVA followed by Tukey's test) 
 
Table 4 — Effect of M. deserti’s Infusion Extract Aerial Parts on Yeast Induced Pyrexia in Rats 
Groups Dose Before yeast After yeast  Time after treatment (h) 
0 h 19 h 1 h 2 h 3 h 4 h 
Control  36.93±0.1 38.08±0.1 38.16±0.3 38.23±0.3 38.46±0.2 38.61±0.3 
Paracetamol 100 mg/kg 37.48±0.3 38.46±0.3 37.58±0.3* 37.1±0.4** 37.31±0.3** 36.98±0.3** 
Infusion extract of M. 
deserti De Noé 
250 mg/kg 37.1±0.1 38.66±0.2 37.55±0.3* 37.33±0.5** 36.93±0.6** 36.68±0.5** 
500 mg/kg 36.6±0.3 38.2±0.2 37.93±0.3* 37.55±0.4** 36.96±0.5** 36.85±0.3** 
1000 mg/kg 36.68±0.3 38.33±0.2 38.05±0.4* 38.1±0.4**£ 37.46±0.3** 37.48±0.4** 
Values represent mean±SD, (n=6).*p<0.05, **p<0.001 significant compared to control, £p<0.05 significant compared to paracetamol
(one way ANOVA followed by Tukey's test). 
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dose (1000 mg/kg bw) did not elicit a greater 
reduction from yeast induced pyrexia as would have 
been expected. However, the infusion extract at the 
dose of 250 mg/kg bw showed the highest activity 
even more than the reference drug (Paracetamol, 100 
mg/kg bw). 
 
Discussion 
In this study, antinociceptive and antipyretic 
activities of the infusion extract of M. deserti De Noé 
aerial parts were evaluated in addition to the 
determination of its acute toxicity profile. The 
antinociceptive potential was assessed using the 
chemicals (acetic acid and formalin) and the thermal 
stimuli models (hot plate test) in mice, while the 
antipyretic test was evaluated on yeast induced 
pyrexia in rats. The obtained results showed that the 
infusion extract of this plant demonstrate high 
significant (p<0.001) effects in all the models used 
while the acute toxicity results indicate that the M. 
deserti’s infusion extract is harmless for the medicinal 
use as the relatively high LD50 value (>13 g/kg) from 
a single exposure, probably suggests that this plant is 
safe. 
In an attempt to determine whether the infusion 
extract attenuated either the peripheral or central, or 
both levels of nociception, acetic acid induced 
writhing, formalin induced paw licking and thermal 
induced nociceptive tests were performed.  
 Acetic acid, the peripheral analgesic agent, causes 
inflammatory pain by inducing abdominal 
constrictions and stretching of hind limbs43. Recently, 
it has been found that this response is mediated by the 
prostaglandin pathways44. Therefore, the agent 
reducing the number of writhing will provide 
analgesic effect preferably by inhibition of 
prostaglandin synthesis, a peripheral mechanism of 
pain inhibition45. Our results showed that the infusion 
extract of M. deserti De Noé in dose-dependent 
manner caused high significant (p<0.001) reduction 
in the number of writhes. The ability of the infusion 
extract of M. deserti De Noé aerial parts to attenuate 
the acetic acid induced writhing response test 
indicates the presence of analgesic compounds that 
might influence the prostaglandin pathways.  
 The formalin test is a model of continuing pain 
including peripheral inflammation and central 
sensitization. The injection of formalin into the mouse 
hind paw initiates triphasic spontaneous nociceptive 
behaviors consisting of flinching, licking and/or biting 
of the injected paw2. This method shows a biphasic 
response, the early phase, classified as a neurogenic 
pain, is an acute response observed immediately after 
the administration of formalin and lasts for 5 min (0–5 
min) as a result of an immediate action of injected 
formalin on nociceptors. The late phase, classified as 
an inflammatory pain, is a tonic response resulting 
from the inflammatory processes generated by the 
release of inflammatory mediators such as histamine, 
serotonin, prostaglandin and bradykinin46 and the 
activation of the neurons in the dorsal horns of the 
spinal cord which appears between 15 and 60 min 
after the formalin administration47-48. The results of 
the present study showed that the infusion extract of 
M. deserti De Noé produced antinociceptive activity 
against both neurogenic and inflammatory phases of 
formalin induction which suggests that it contain 
active analgesic principles acting centrally and 
peripherally, where the last action is supported by the 
results recorded in the acetic acid induced writhing 
test. 
 Another model of nociception that has been widely 
used to further support the antinociceptive effect 
observed in any new compound or extract is the 
thermal induced nociceptive model or hot plate test. 
The hot plate test measures the response to a brief, 
noxious stimulus having a close resemblance to 
clinical pain. This test measures the complex 
responses to a non-inflammatory, acute nociceptive 
impulse and is one of the selective models for 
studying only the central antinociceptive activity49. 
Drugs that act centrally activate the release of 
endogenous peptides, which is then carried to the 
spinal cord to inhibit the pain impulse transmission 
within the dorsal horn50. Based on the ability of the 
infusion extract to prolong the latency on hot plate, 
we suggest that this extract possessed centrally 
mediated antinociceptive activity against the thermal 
induced nociception.  
To investigate the antipyretic effect of M. deserti’s 
infusion extract, the yeast induced pyrexia test in rat was 
carried out. Antipyretic activity is a characteristic of 
drugs or compounds which have an inhibitory effect on 
prostaglandin biosynthesis51. It is well known that 
pyretic activity involves stimulation of the region in the 
hypothalamus that controls body temperature; via 
prostanglandins synthesized within the central nervous 
system and that the blood-brain barrier prevents drug 
molecules or other chemicals from entering the central 
nervous system44. Regulation of body temperature 
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requires a delicate balance between production and loss 
of heat, and the hypothalamus regulates the set point at 
which body temperature is maintained52. The infusion 
extract of M. deserti De Noé aerial parts possesses a 
significant antipyretic effect in yeast-induced 
temperature in rats. So, we suggest that this extract may 
exhibit central action because pyrexia is central 
processes42. 
Furthermore, the chemical screening for compounds 
known for their potential activities was investigated. 
Phytochemical screening of the infusion extract of M. 
deserti De Noé aerial parts indicates the presence of 
tannins, alkaloids, steroids, terpenoids and a high 
amount of phenolic compounds. Flavonoids constitute a 
wide array of biologically active compounds that are 
found abundantly in plant kingdom and dietary intake. 
They are reported to be effective against different 
diseases such as antioxidant, analgesic, anti-
inflammatory53-55, antimicrobial56, hepatoprotective57 
and anticancer25 activities. Furthermore, condensed 
tannins have been suggested to possess free radical 
scavenging and antioxidant, anti-inflammatory, and 
hepatoprotective activities58. Besides, alkaloids are well 
known for their abilities to inhibit pain perception1. 
Based on these reports, it is possible that the 
antinociceptive and antipyretic activities of the infusion 
extract of M. deserti De Noé may be due to the presence 
and the action of flavonoids, tannins, alkaloids or 
terpenoids. 
 
Conclusion 
To the best of our knowledge, this work reveals, for 
the first time, that Marrubium deserti De Noé infusion 
extract possesses antinociceptive and antipyretic effects, 
suggesting that the mechanism of action seems to be 
similar to NSAIDs drugs such as paracetamol. It has 
been proved that M. deserti De Noé has obvious 
beneficial effects against centrally and peripherally pain 
models. The relatively high LD50 value (>13 g/kg bw) 
obtained for the plant shows that it is safe. These 
findings justify the use of this plant in the Algerian 
traditional medicine in the treatment of various types of 
inflammations and pains. However, the chemical 
constituents responsible for the pharmacological 
activities remain to be investigated. 
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